Please use this identifier to cite or link to this item: https://dspace.iiti.ac.in/handle/123456789/12003
Title: Molecular dynamics simulations reveal phosphorylation-induced conformational dynamics of the fibroblast growth factor receptor 1 kinase
Authors: Mahapatra, Subhasmita
Jonniya, Nisha Amarnath
Koirala, Suman
Kar, Parimal
Keywords: conformational dynamics;FGFR1;molecular dynamics;PCA (principal component analysis);phosphorylation
Issue Date: 2023
Publisher: Taylor and Francis Ltd.
Citation: Mahapatra, S., Jonniya, N. A., Koirala, S., & Kar, P. (2023). Molecular dynamics simulations reveal phosphorylation-induced conformational dynamics of the fibroblast growth factor receptor 1 kinase. Journal of Biomolecular Structure and Dynamics, doi:10.1080/07391102.2023.2209189
Abstract: The Fibroblast Growth Factor Receptor1 (FGFR1) kinase wields exquisite control on cell fate, proliferation, differentiation, and homeostasis. An imbalance of FGFR1 signaling leads to several pathogeneses of diseases ranging from multiple cancers to allergic and neurodegenerative disorders. In this study, we investigated the phosphorylation-induced conformational dynamics of FGFR1 in apo and ATP-bound states via all-atom molecular dynamics simulations. All simulations were performed for 2 × 2 µs. We have also investigated the energetics of the binding of ATP to FGFR1 using the molecular mechanics Poisson-Boltzmann scheme. Our study reveals that the FGFR1 kinase can reach a fully active configuration through phosphorylation and ATP binding. A 3–10 helix formation in the activation loop signifies its rearrangement leading to stability upon ATP binding. The interaction of phosphorylated tyrosine (pTyr654) with positively charged residues forms strong salt-bridge interactions, driving the compactness of the structure. The dynamic cross-correlation map reveals phosphorylation enhances correlated motions and reduces anti-correlated motions between different domains. We believe that the mechanistic understanding of large-conformational changes upon the activation of the FGFR1 kinase will aid the development of novel targeted therapeutics. Communicated by Ramaswamy H. Sarma. © 2023 Informa UK Limited, trading as Taylor & Francis Group.
URI: https://doi.org/10.1080/07391102.2023.2209189
https://dspace.iiti.ac.in/handle/123456789/12003
ISSN: 0739-1102
Type of Material: Journal Article
Appears in Collections:Department of Biosciences and Biomedical Engineering

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetric Badge: